GOLM1 and hepatocellular carcinoma: The serum levels of GP73 were higher in HCC patients with cirrhosis, than in those without cirrhosis (median [IQR], 122.00 [79.58–180.50] ng/ml vs. 49.44 [32.19–67.09]) ng/ml, (P < 0.0001) (Figure 2B).